Bota Biosciences (Bota Bio) is a global industrial biotechnology company connecting biological design to scale-up manufacturing to accelerate shifts to sustainable living. Bota has built an integrative bioengineering platform, to develop and implement efficient, eco-friendly, and cost-effective biomanufacturing technologies. Committed to its mission, Bota established its own pilot plant and manufacturing facility, affirming its dedication to offering scalable industrial solutions and market-ready products. This infrastructure strengthens support for customers and partners across industries such as nutrition, food, personal care, and animal health.
Powered by a dynamic, multidisciplinary team, Bota Bio channels biotech innovations to create a global impact. The company's Series B financing has surpassed $100 million, bringing its aggregate funding to $145 million, with investment from notable strategic and financial investors, including Hong Shan Capital, Matrix Partners, and BASF Ventures.
Company Details
- Employees
- 34
- Founded
- -
- Address
- 3515 Mt Diablo Blvd, Lafayette,california 94549,united States
- Industry
- Biotechnology
- Website
- https://bota.bio/en
- HQ
- Lafayette, California
Bota Biosciences Questions
Bota Biosciences's website is https://bota.bio/en
Bota Biosciences's LinkedIn profile is https://www.linkedin.com/company/botabio
Bota Biosciences has
34 employees.
View email and phone details for 34
employees at Bota Biosciences.
Bota Biosciences's industry is
Biotechnology
Bota Biosciences's top competitors are
Syensqo,
Evolutia Bio,
Zymochem,
Evercrisp Biosciences,
Nest.bio,
Exozymes (Nasdaq: Exoz),
Puratos,
Mission Barns,
Fancytech,
Bitbiome, Inc..
Bota Biosciences's categories are Biotechnology
Bota Biosciences's founding year is 2019
